ICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.
- Revenue
- +4.37%
- EPS
- +864.3%
- Free cash flow
- +292.2%
- Total debt
- −12.3%
Quarter to September 2026, against a year earlier
Follow ICUI
Alert me
ICU Medical, Inc. (ICUI) P/B ratio
As of 5 November 2026, ICU Medical, Inc. (ICUI) trades at a P/B ratio of 1.9×. Over the past ten years it has ranged from 0.9× (November 2023) to 5.1× (June 2018); the current reading is higher than 27% of that period. That is below the Medical Instruments & Supplies industry median of 2.3× and below the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.7× | (14.04%) |
| FY2024 | 1.9× | 67.08% |
| FY2023 | 1.2× | (36.85%) |
| FY2022 | 1.8× | (41.40%) |
| FY2021 | 3.1× | 4.33% |
| FY2020 | 3.0× | 6.50% |
| FY2019 | 2.8× | (24.37%) |
| FY2018 | 3.7× | 4.77% |
| FY2017 | 3.5× | (1.88%) |
| FY2016 | 3.6× | 16.96% |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 1.8× | 7.54% |
| Jun 2026 | 1.7× | 12.47% |
| Mar 2026 | 1.5× | (8.51%) |
| Dec 2025 | 1.7× | 18.90% |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| NVST Envista Holdings Corporation compare | 1.3× |
| MMED MiniMed Group, Inc. compare | 1.4× |
| ICUI ICU Medical, Inc. | 1.9× |
| STVN Stevanato Group S.p.A. compare | 2.0× |
| TFX Teleflex Incorporated compare | 2.3× |
| MMSI Merit Medical Systems, Inc. compare | 3.1× |
| ATRC AtriCure, Inc. compare | 5.6× |
| WRBY Warby Parker Inc. compare | 8.1× |
| PLSE Pulse Biosciences, Inc compare | 20.8× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on ICUI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement